摘要
背景:虽然顺铂和一些铂络合物已广泛用于治疗瘤形成,但接受这些治疗的患者经常遭受其严重毒副作用,发展抗性并随之复发近几十年来,已经报道了包括金,铜和银在内的造币金属的许多复合物展现出有希望的体外和/或体内抗癌活性以及对顺铂抗性肿瘤的有效活性。尽管如此,这些金属配合物的医学发展受到其在水溶液中的不稳定性和生物系统中的非特异性结合的阻碍。 方法:克服这些问题的方法之一是设计和开发用于运输这些复合物的适当的药物递送系统(DDS)通过官能化,包封或配制金属配合物,已报道几种类型的DDS改善金属配合物的所需药理学特性,改善其整体稳定性,生物利用度,抗癌活性并降低其对正常细胞的毒性。 结论:在这篇综述中,我们总结了不同DDSs对于某些造币金属的各种抗癌活性复合物的最新发现。
关键词: 癌症,铸币金属,铜,药物输送系统,黄金,白银。
Current Medicinal Chemistry
Title:Drug Delivery Systems For Anti-Cancer Active Complexes of Some Coinage Metals
Volume: 25 Issue: 4
关键词: 癌症,铸币金属,铜,药物输送系统,黄金,白银。
摘要: Background: Although cisplatin and a number of platinum complexes have widely been used for the treatment of neoplasia, patients receiving these treatments have frequently suffered from their severe toxic side effects, the development of resistance with consequent relapse. In the recent decades, numerous complexes of coinage metals including that of gold, copper and silver have been reported to display promising in vitro and/or in vivo anti-cancer activities as well as potent activities towards cisplatin-resistant tumors. Nevertheless, the medical development of these metal complexes has been hampered by their instability in aqueous solutions and the nonspecific binding in biological systems.
Methods: One of the approaches to overcome these problems is to design and develop adequate drug delivery systems (DDSs) for the transport of these complexes. By functionalization, encapsulation or formulation of the metal complexes, several types of DDSs have been reported to improve the desired pharmacological profile of the metal complexes, improving their overall stability, bioavailability, anti-cancer activity and reducing their toxicity towards normal cells.
Conclusion: In this review, we summarized the recent findings for different DDSs for various anti- cancer active complexes of some coinage metals.
Export Options
About this article
Cite this article as:
Drug Delivery Systems For Anti-Cancer Active Complexes of Some Coinage Metals, Current Medicinal Chemistry 2018; 25 (4) . https://dx.doi.org/10.2174/0929867324666170511152441
DOI https://dx.doi.org/10.2174/0929867324666170511152441 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pembrolizumab-Induced Seronegative Arthritis and Fasciitis in a Patient with Lung Adenocarcinoma
Current Drug Safety Benzo[d]imidazol-5-yl)-5-(substituted)-1,3,4-Oxadiazoles: Synthesis, Anticancer, Antimicrobial and In Silico Studies
Letters in Drug Design & Discovery Treasures Hunt in Old Mines: Terminalia chebula-Based Traditional Herbal Medicinal Products
The Natural Products Journal Inhibition of Transcription Factors by Plant-Derived Compounds and their Implications in Inflammation and Cancer
Current Pharmaceutical Design The Delivery of Biologically Active (Therapeutic) Peptides and Proteins into Cells
Current Medicinal Chemistry Oxycodone/Naloxone in the Management of Patients with Pain and Opioid–Induced Bowel Dysfunction
Current Drug Targets Pharmacological Modulation of Genome and Proteome Alterations in Mice Treated with the Endocrine Disruptor Bisphenol A
Current Cancer Drug Targets The Extracellular Matrix Regulates Cancer Progression and Therapy Response: Implications for Prognosis and Treatment
Current Pharmaceutical Design Quinazolines as Apoptosis Inducers and Inhibitors: A Review of Patent Literature
Recent Patents on Anti-Cancer Drug Discovery Cancer Nanotheranostics: A Nanomedicinal Approach for Cancer Therapy and Diagnosis
Anti-Cancer Agents in Medicinal Chemistry An Insight into Patents of Fluoroquinolone Derivatives
Letters in Drug Design & Discovery The Spleen Tyrosine Kinase (Syk) in Human Disease, Implications for Design of Tyrosine Kinase Inhibitor Based Therapy
Current Pharmaceutical Design Cystathionine β-synthase Induces Multidrug Resistance and Metastasis in Hepatocellular Carcinoma
Current Molecular Medicine NLRP3 Inhibitors as Potential Therapeutic Agents for Treatment of Inflammatory Bowel Disease
Current Pharmaceutical Design pH-Dependent Thermal Stability of Vibrio cholerae L-asparaginase
Protein & Peptide Letters Mechanisms of Enhanced Vasoconstriction in the Mouse Model of Atherosclerosis: the Beneficial Effects of Sildenafil
Current Pharmaceutical Biotechnology Kringle Structures and Antiangiogenesis
Current Medicinal Chemistry - Anti-Cancer Agents Chemical Structure and Surface Modification of Dendritic Nanomaterials Tailored for Therapeutic and Diagnostic Applications
Current Topics in Medicinal Chemistry Chemotherapy of Breast Cancer in the Elderly
Current Medicinal Chemistry FoxO1 Inhibitors: The Future Medicine for Metabolic Disorders?
Current Diabetes Reviews